BAAM
MRTX

Baker Avenue Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Baker Avenue Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$653 – 1573
2023
Q3 		$653 Buy
15
+9
+150% +$392 ﹤0.01% 1364
2023
Q2 		$217 Buy
+6
New +$217 ﹤0.01% 1552